§ 17-10302

D.C. Mun. Regs. tit. 17, § 10302

Covered Substances

Effective Jun 7, 201966 DCR 6830Authority: Sections 3 and 11 of the Prescription Drug Monitoring Program Act of 2013, effective February 22, 2014 (D.C. Law 20-66; D.C. Official Code §§ 48-853.02 and 48-853.10 (2014 Repl. & 2015 Supp.)). Source: Final Rulemaking published at 62 DCR 15828 (December 11, 2015); as amended by Final Rulemaking published at 66 DCR 6830 (June 7, 2019).District of Columbia, Office of the Secretary

10302.1 Covered substances are controlled substances, as defined in this rulemaking, and the following drugs of concern:

(a) All drug products containing Cyclobenzaprine;
(b) All drug products containing Butalbital; and
(c) All drug products containing Gabapentin.

SOURCE: Final Rulemaking published at 62 DCR 15828 (December 11, 2015); as amended by Final Rulemaking published at 66 DCR 6830 (June 7, 2019).